These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 18158033

  • 1. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.
    Pepe P, Aragona F.
    Urology; 2007 Dec; 70(6):1131-5. PubMed ID: 18158033
    [Abstract] [Full Text] [Related]

  • 2. Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed?
    Pepe P, Fraggetta F, Galia A, Grasso G, Piccolo S, Aragona F.
    Urology; 2008 Dec; 72(6):1198-202. PubMed ID: 19041023
    [Abstract] [Full Text] [Related]

  • 3. Is a single focus of low-grade prostate cancer diagnosed on saturation biopsy predictive of clinically insignificant cancer?
    Pepe P, Fraggetta F, Galia A, Candiano G, Grasso G, Aragona F.
    Urol Int; 2010 Dec; 84(4):440-4. PubMed ID: 20234121
    [Abstract] [Full Text] [Related]

  • 4. Prostate biopsy: who, how and when. An update.
    Djavan B, Milani S, Remzi M.
    Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [Abstract] [Full Text] [Related]

  • 5. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
    Lane BR, Zippe CD, Abouassaly R, Schoenfield L, Magi-Galluzzi C, Jones JS.
    J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
    [Abstract] [Full Text] [Related]

  • 6. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L, Jones JS, Zippe CD, Reuther AM, Klein E, Zhou M, Magi-Galluzzi C.
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [Abstract] [Full Text] [Related]

  • 7. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
    Campos-Fernandes JL, Bastien L, Nicolaiew N, Robert G, Terry S, Vacherot F, Salomon L, Allory Y, Vordos D, Hoznek A, Yiou R, Patard JJ, Abbou CC, de la Taille A.
    Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923
    [Abstract] [Full Text] [Related]

  • 8. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
    Guichard G, Larré S, Gallina A, Lazar A, Faucon H, Chemama S, Allory Y, Patard JJ, Vordos D, Hoznek A, Yiou R, Salomon L, Abbou CC, de la Taille A.
    Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
    [Abstract] [Full Text] [Related]

  • 9. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME.
    Clin Lab Sci; 2001 Aug; 14(2):102-7. PubMed ID: 15625982
    [Abstract] [Full Text] [Related]

  • 10. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
    Luciani LG, De Giorgi G, Valotto C, Zanin M, Bierti S, Zattoni F.
    Urology; 2006 Mar; 67(3):555-8. PubMed ID: 16527579
    [Abstract] [Full Text] [Related]

  • 11. Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
    Ahyai SA, Graefen M, Steuber T, Haese A, Schlomm T, Walz J, Köllermann J, Briganti A, Zacharias M, Friedrich MG, Karakiewicz PI, Montorsi F, Huland H, Chun FK.
    Eur Urol; 2008 Apr; 53(4):750-7. PubMed ID: 17964070
    [Abstract] [Full Text] [Related]

  • 12. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
    Eskicorapci SY, Guliyev F, Akdogan B, Dogan HS, Ergen A, Ozen H.
    J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481
    [Abstract] [Full Text] [Related]

  • 13. Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy.
    Yokomizo Y, Miyoshi Y, Nakaigawa N, Makiyama K, Ogawa T, Yao M, Kubota Y, Uemura H.
    Urol Int; 2009 May; 82(3):280-5. PubMed ID: 19440014
    [Abstract] [Full Text] [Related]

  • 14. Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings.
    Inahara M, Suzuki H, Kojima S, Komiya A, Fukasawa S, Imamoto T, Naya Y, Ichikawa T.
    Urology; 2006 Oct; 68(4):815-9. PubMed ID: 17070359
    [Abstract] [Full Text] [Related]

  • 15. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS, Swords K, Schultz H, Carson CC, Wallen EM.
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Potential benefit of transrectal saturation prostate biopsy as an initial biopsy strategy: decreased likelihood of finding significant cancer on future biopsy.
    Li YH, Elshafei A, Li J, Hatem A, Zippe CD, Fareed K, Jones JS.
    Urology; 2014 Apr; 83(4):714-8. PubMed ID: 24680442
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N, Lane BR, Li J, Moussa AS, Soriano M, Jones JS.
    J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.